ATE525093T1 - Modelle für die bewertung von impfstoffen - Google Patents
Modelle für die bewertung von impfstoffenInfo
- Publication number
- ATE525093T1 ATE525093T1 AT07872536T AT07872536T ATE525093T1 AT E525093 T1 ATE525093 T1 AT E525093T1 AT 07872536 T AT07872536 T AT 07872536T AT 07872536 T AT07872536 T AT 07872536T AT E525093 T1 ATE525093 T1 AT E525093T1
- Authority
- AT
- Austria
- Prior art keywords
- models
- vaccine evaluation
- vaccine
- evaluation
- population
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81663706P | 2006-06-27 | 2006-06-27 | |
PCT/US2007/014826 WO2008094178A2 (en) | 2006-06-27 | 2007-06-27 | Models for vaccine assessment |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE525093T1 true ATE525093T1 (de) | 2011-10-15 |
Family
ID=39674632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07872536T ATE525093T1 (de) | 2006-06-27 | 2007-06-27 | Modelle für die bewertung von impfstoffen |
Country Status (6)
Country | Link |
---|---|
US (2) | US7709257B2 (de) |
EP (3) | EP2043695B8 (de) |
AT (1) | ATE525093T1 (de) |
AU (1) | AU2007345747A1 (de) |
CA (1) | CA2655344C (de) |
WO (1) | WO2008094178A2 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8030070B2 (en) * | 2004-04-28 | 2011-10-04 | Sanofi Pasteur Vaxdesign Corp. | Artificial lymphoid tissue equivalent |
US8298824B2 (en) | 2004-04-28 | 2012-10-30 | Sanofi Pasteur Vaxdesign Corporation | Methods of evaluating a test agent in a diseased cell model |
US7771999B2 (en) | 2004-04-28 | 2010-08-10 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US7785883B2 (en) | 2004-04-28 | 2010-08-31 | Vax Design Corp. | Automatable artificial immune system (AIS) |
US8071373B2 (en) | 2004-04-28 | 2011-12-06 | Sanofi Pasteur Vaxdesign Corp. | Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) |
US7855074B2 (en) | 2004-04-28 | 2010-12-21 | Vaxdesign Corp. | Artificial immune system: methods for making and use |
US7709256B2 (en) * | 2004-04-28 | 2010-05-04 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US7785806B2 (en) * | 2004-04-28 | 2010-08-31 | Vaxdesign Corporation | Method for determining the immunogenicity of an antigen |
AU2006331504A1 (en) | 2005-12-21 | 2007-07-05 | Vaxdesign Corporation | In vitro germinal centers |
ATE495238T1 (de) * | 2005-12-21 | 2011-01-15 | Vaxdesign Corp | Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen |
EP2043695B8 (de) * | 2006-06-27 | 2012-02-29 | Sanofi Pasteur VaxDesign Corporation | Modelle für die bewertung von impfstoffen |
WO2009048661A1 (en) | 2007-07-16 | 2009-04-16 | Vaxdesign Corporation | Artificial tissue constructs comprising alveolar cells and methods for using the same |
US20090328240A1 (en) * | 2008-06-24 | 2009-12-31 | Sing George L | Genetically modified mice as predictors of immune response |
DK3028565T3 (da) | 2009-07-08 | 2017-11-13 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
US20120204278A1 (en) | 2009-07-08 | 2012-08-09 | Kymab Limited | Animal models and therapeutic molecules |
US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
WO2011066221A1 (en) * | 2009-11-24 | 2011-06-03 | International Aids Vaccine Initiative | Immunogen prioritization for vaccine design |
EP2422618A1 (de) * | 2010-08-27 | 2012-02-29 | Technologie Integrale Ltd. | Tiermodell zur Beurteilung der Wirksamkeit eines HIV-Impfstoffs |
EP4091442A1 (de) | 2011-09-19 | 2022-11-23 | Kymab Limited | Manipulation der immunglobulin-gen-vielfalt und therapeutika mit mehreren antikörpern |
EP2761008A1 (de) | 2011-09-26 | 2014-08-06 | Kymab Limited | Chimäre surrogatleichtketten (slc) mit humanem vpreb |
US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
EP2822578A4 (de) * | 2012-03-07 | 2015-10-07 | Childrens Medical Center | Gewebekonstrukte und verwendungen davon |
US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
US9783618B2 (en) | 2013-05-01 | 2017-10-10 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
SG11201602236SA (en) | 2013-10-01 | 2016-04-28 | Kymab Ltd | Animal models and therapeutic molecules |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
US5720937A (en) * | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
US5008116A (en) * | 1988-11-14 | 1991-04-16 | Frederick Cahn | Immunostimulatory microsphere |
US5562910A (en) * | 1989-09-25 | 1996-10-08 | University Of Utah Research Foundation | Vaccine compositions and method for enhancing an immune response |
US5188959A (en) * | 1989-09-28 | 1993-02-23 | Trustees Of Tufts College | Extracellular matrix protein adherent t cells |
US5695996A (en) * | 1994-09-23 | 1997-12-09 | The United States Of America As Represented By The Department Of Health And Human Services | Artificial organ culture system |
US6479258B1 (en) * | 1995-12-07 | 2002-11-12 | Diversa Corporation | Non-stochastic generation of genetic vaccines |
US5739001A (en) * | 1996-10-29 | 1998-04-14 | E. I. Du Pont De Nemours And Company | Solid phase cell-based assay |
US6177282B1 (en) * | 1997-08-12 | 2001-01-23 | Mcintyre John A. | Antigens embedded in thermoplastic |
WO1999015629A1 (en) | 1997-09-25 | 1999-04-01 | Cytomatrix, Llc | Methods and devices for the long-term culture of hematopoietic progenitor cells |
EP2058389B1 (de) * | 1997-10-27 | 2016-05-18 | Rockefeller University | Definiertes Reifungsmedium für dendritische Zellen enthaltend TNF-alpha, IL-1beta, IL-6 |
AU2797799A (en) | 1998-02-27 | 1999-09-15 | Anticancer, Inc. | (in vitro) model for viral infection and immune response |
AU2848099A (en) | 1998-03-25 | 1999-10-18 | Gert Blankenstein | Micro system and method for field manipulation of particules |
US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US20020155108A1 (en) * | 1998-05-04 | 2002-10-24 | Biocrystal, Ltd. | Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells |
WO2001034646A2 (en) | 1999-11-12 | 2001-05-17 | Fibrogen, Inc. | Recombinant gelatins |
JP2003530826A (ja) * | 1999-11-17 | 2003-10-21 | ユニバーシティー オブ ロチェスター | ヒトのエキソビボ免疫系 |
US6479064B1 (en) * | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
US6541225B1 (en) * | 2000-01-26 | 2003-04-01 | Raven Biotechnologies, Inc. | Methods and compositions for generating human monoclonal antibodies |
JP2004522446A (ja) * | 2001-02-07 | 2004-07-29 | コリア アトミック エネルギー リサーチ インスティテュート | 上皮細胞の分離方法、細胞を前条件付けする方法、およびバイオ人工皮膚もしくは真皮を上皮細胞または条件付けされた細胞を用いて調製する方法 |
EP1437147B1 (de) | 2001-09-25 | 2012-06-27 | National Institute for Environmental Studies | Verfahren zur herstellung einer grundmembran |
US20030166274A1 (en) | 2001-11-15 | 2003-09-04 | Hewitt Charles W. | Three-dimensional matrix for producing living tissue equivalents |
FR2833271B1 (fr) | 2001-12-10 | 2004-09-17 | Coletica | Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles |
GB0130789D0 (en) * | 2001-12-21 | 2002-02-06 | King S College London | Application of spores |
AU2003265229A1 (en) * | 2002-03-18 | 2003-12-12 | Sciperio, Inc. | Dentritic cell nodes |
ES2379252T3 (es) * | 2002-04-11 | 2012-04-24 | Cyclex, Inc. | Método para monitorizar la respuesta inmunitaria y predecir los desenlaces clínicos en receptores de trasplantes |
US20040009943A1 (en) * | 2002-05-10 | 2004-01-15 | Inex Pharmaceuticals Corporation | Pathogen vaccines and methods for using the same |
US20050191743A1 (en) * | 2002-10-03 | 2005-09-01 | Wu J.H. D. | Three-dimensional peripheral lymphoid organ cell cultures |
US20040109876A1 (en) * | 2002-11-25 | 2004-06-10 | Kureha Chemical Industry Co., Ltd. | Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV |
EP1479760A1 (de) | 2003-05-19 | 2004-11-24 | ProBioGen AG | Künstliches Immunorgan |
US7855074B2 (en) * | 2004-04-28 | 2010-12-21 | Vaxdesign Corp. | Artificial immune system: methods for making and use |
US7785883B2 (en) * | 2004-04-28 | 2010-08-31 | Vax Design Corp. | Automatable artificial immune system (AIS) |
US20060275270A1 (en) * | 2004-04-28 | 2006-12-07 | Warren William L | In vitro mucosal tissue equivalent |
AU2005237588B2 (en) * | 2004-04-28 | 2010-07-08 | Massachusetts Institute Of Technology | Artificial immune system: methods for making and use |
US20070141552A1 (en) * | 2004-04-28 | 2007-06-21 | Warren William L | Automatable artificial immune system (AIS) |
US8071373B2 (en) * | 2004-04-28 | 2011-12-06 | Sanofi Pasteur Vaxdesign Corp. | Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) |
US8030070B2 (en) * | 2004-04-28 | 2011-10-04 | Sanofi Pasteur Vaxdesign Corp. | Artificial lymphoid tissue equivalent |
US7771999B2 (en) * | 2004-04-28 | 2010-08-10 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US7709256B2 (en) * | 2004-04-28 | 2010-05-04 | Vaxdesign Corp. | Disease model incorporation into an artificial immune system (AIS) |
US7785806B2 (en) * | 2004-04-28 | 2010-08-31 | Vaxdesign Corporation | Method for determining the immunogenicity of an antigen |
EP1782255A4 (de) * | 2004-06-09 | 2009-04-29 | Us Bancorp Licensing Inc | Transaktionsverarbeitung mit kern- und verteilerprozessorimplementierungen |
EP1970444A4 (de) | 2005-12-12 | 2010-01-20 | Riken | Verfahren zur herstellung eines antigenspezifischen hybridoms unter verwendung eines künstlichen lymphknotens mit guter effizienz |
AU2006331504A1 (en) * | 2005-12-21 | 2007-07-05 | Vaxdesign Corporation | In vitro germinal centers |
ATE495238T1 (de) * | 2005-12-21 | 2011-01-15 | Vaxdesign Corp | Iin vitro methode um eine potentielle reaktion eines tieres an einen agenten zu bestimmen |
EP2043695B8 (de) | 2006-06-27 | 2012-02-29 | Sanofi Pasteur VaxDesign Corporation | Modelle für die bewertung von impfstoffen |
AU2008275296A1 (en) * | 2007-07-06 | 2009-01-15 | Sanofi Pasteur Vaxdesign Corporation | Rapid generation of T cell-independent antibody responses to T cell-dependent antigens |
-
2007
- 2007-06-27 EP EP07872536A patent/EP2043695B8/de active Active
- 2007-06-27 CA CA2655344A patent/CA2655344C/en active Active
- 2007-06-27 WO PCT/US2007/014826 patent/WO2008094178A2/en active Application Filing
- 2007-06-27 US US11/819,335 patent/US7709257B2/en active Active
- 2007-06-27 AT AT07872536T patent/ATE525093T1/de not_active IP Right Cessation
- 2007-06-27 AU AU2007345747A patent/AU2007345747A1/en not_active Abandoned
- 2007-06-27 EP EP11165212A patent/EP2409715A1/de not_active Withdrawn
- 2007-06-27 EP EP11165211A patent/EP2409714A1/de not_active Withdrawn
-
2010
- 2010-03-17 US US12/726,054 patent/US20100287630A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2043695B8 (de) | 2012-02-29 |
US20080008653A1 (en) | 2008-01-10 |
AU2007345747A1 (en) | 2008-08-07 |
CA2655344A1 (en) | 2008-08-07 |
WO2008094178A2 (en) | 2008-08-07 |
EP2043695A2 (de) | 2009-04-08 |
WO2008094178A9 (en) | 2008-10-02 |
US7709257B2 (en) | 2010-05-04 |
EP2409715A1 (de) | 2012-01-25 |
EP2043695B1 (de) | 2011-09-21 |
EP2409714A1 (de) | 2012-01-25 |
US20100287630A1 (en) | 2010-11-11 |
CA2655344C (en) | 2016-09-13 |
WO2008094178A3 (en) | 2009-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE525093T1 (de) | Modelle für die bewertung von impfstoffen | |
BRPI0710123A2 (pt) | Previsão de heterose e outros traços por análise de transcriptoma. | |
DE60334325D1 (de) | Brandüberwachungssystem für aufzug | |
DE602006010967D1 (de) | Reise-Verknüpfungsidentifikationssystem | |
FI20055581A0 (fi) | Erotusmenetelmä | |
DE602004009718D1 (de) | Gerät für die Zubereitung von Getränken | |
DE602006000526D1 (de) | Vorrichtung zur Unterscheidung von Münzwerten | |
DE602004021987D1 (de) | Vorrichtung zum Ölabscheiden für einen Kühlmittelkompressor | |
DE602004001247D1 (de) | Initiator für die Photopolymerisation | |
ATE401789T1 (de) | Vorrichtung | |
DE602006009513D1 (de) | Verwendung von phenylsemicarbazonen für die saatgutbeizung | |
DE60303851D1 (de) | Trennbare Schnürverbindung für eine Notrutsche | |
DE602006020904D1 (de) | Verfahren zum testen von antigen | |
DE602005010032D1 (de) | Lese-/Schreibeinrichtung für einen analytischenTest | |
DK1894169T3 (da) | Identifikationskort | |
DE602006002927D1 (de) | Käfiganordnung für eine Käfigmutter | |
DE602005008351D1 (de) | Pneumatisches Gewichtsausgleichssystem | |
ATE286839T1 (de) | Schaupackung für z.b. eier | |
DE502006006964D1 (de) | Lichtquelle für die Endoskopie oder Mikroskopie | |
DE502005010620D1 (de) | Obergurtquerschnitt für Kranteleskopteile | |
DE602006007295D1 (de) | Informationsverarbeitungsvorrichtung | |
FI20051312L (fi) | Laadunarviointimenetelmä | |
DE602005020266D1 (de) | Vorrichtung zum vereinzeln von objekten | |
DE502004004004D1 (de) | Wechselrahmen für Plakate | |
DE602004026151D1 (de) | Vorrichtung zur Abnahme von Medien für einen Medienausgeber |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |